Disclosure: This article is published by Subthesis, which offers free research tools that compete with some of the products discussed here. Subthesis is not affiliated with Covidence, and Covidence did not review or endorse this article. Product details and prices were checked against public sources in September 2026 and may have changed since.
Graduate students often start searching for Covidence alternatives at the same point: they have begun a review, found that their institution does not hold a license, and seen the $339 per year price for a single review. Before deciding whether to pay, it helps to answer a more basic question: is the project a formal systematic review, or a structured literature review? The answer determines whether a dedicated screening platform is needed at all.
This guide covers what Covidence does, what it costs as of September 2026, where it is strong, where it may be more than a project needs, and what kinds of alternatives exist for solo researchers and small, unfunded teams.
What Covidence Is and Why Cochrane Teams Use It
Covidence is a web-based systematic review management platform built by Veritas Health Innovation, a Melbourne-based not-for-profit social enterprise, and launched in 2014. It covers the screening and extraction workflow from start to finish: citation import and deduplication, title and abstract screening with multiple blinded reviewers, full-text review, risk of bias assessment, data extraction, and PRISMA flow diagram export. It integrates with EndNote, Zotero, Mendeley, RefWorks, and RevMan, imports citations in RIS, EndNote XML, and PubMed formats, and exports data to CSV. If Zotero is the reference manager feeding that import, see this overview of Zotero alternatives and companions for graduate students.
Covidence reports more than 450 universities and institutions with unlimited access and 2,500+ daily active users across 200 countries. It also has a formal relationship with Cochrane: Cochrane adopted Covidence as its standard production platform in 2015, and it remains the primary screening and data extraction tool recommended for standard Cochrane intervention reviews. In our view, in the health sciences that endorsement is a strong credibility signal.
Covidence Pricing in 2026: What It Actually Costs
The following pricing was checked against Covidence's pricing page and current library guides as of September 2026:
- Free trial: one review capped at 500 records, at no cost. That is enough to sample the workflow, but a health-sciences search can return thousands of records, so for many projects the trial works as a preview rather than a working plan. The paid plans below remove the trial cap.
- Single plan: $339 USD per year for one review, unlimited collaborators, valid 12 months. There is no monthly option and no student discount.
- Package plan: $907 USD per year for up to 3 reviews, unlimited collaborators.
- Organizational plans: custom quoted. Library sources report tiers around $2,500 for small institutions, $5,000 for medium, and $6,500 for large per year, with a first-year introductory rate around $1,250 for small institutions. These include unlimited reviews and users, 24/7 support, training, and some Cochrane Interactive Learning licenses.
- Cochrane authors: registered Cochrane reviews get Covidence access without charge through the partnership.
- Concessions: review teams based in a low or lower-middle income country can contact Covidence about access arrangements.
Two points matter most for students. First, the single-review plan now sits at $339, and library guides from earlier years list lower prices, so older figures you find online may be out of date. Second, pricing is per review, not per user. For a funded team that is, in our view, reasonable; for a solo graduate student paying out of pocket for one dissertation chapter, it is a meaningful expense.
Covidence access options compared
| Access route | Cost (as of September 2026) | Reviews covered | Collaborators | Record limit |
|---|---|---|---|---|
| Free trial | $0 | 1 | Not specified here; check current terms | 500 records |
| Single plan | $339 USD per year | 1 | Unlimited | Trial cap removed |
| Package plan | $907 USD per year | Up to 3 | Unlimited | Trial cap removed |
| Organizational plan | Custom quote (library sources report roughly $2,500 to $6,500 per year by institution size) | Unlimited | Unlimited users | Trial cap removed |
| Cochrane registered review | No charge | Registered Cochrane reviews | Per Cochrane arrangements | Trial cap removed |
| Low or lower-middle income country teams | Contact Covidence | Case by case | Case by case | Case by case |
Do You Actually Need a Systematic Review Platform?
This question comes down to methodology, not software. A systematic review is a formal research method: a pre-registered protocol, an exhaustive search strategy, explicit inclusion and exclusion criteria, screening by two or more independent reviewers, risk of bias assessment, and PRISMA-compliant reporting. If that describes your project, you need real screening infrastructure, and Covidence is one legitimate way to get it.
A structured literature review for a thesis or dissertation is different. In our experience, most graduate literature review chapters, and most narrative and scoping-style reviews, do not require blinded dual screening or a PRISMA flow diagram. What they require is disciplined organization: tracking sources, methods, findings, themes, and gaps across 40 to 150 papers in a way a committee can follow.
For that job, the core tool is usually a literature review matrix (also called a synthesis matrix): one row per source, with columns for study design, sample, outcomes, key findings, limitations, and notes. A matrix can be kept in a spreadsheet, in a reference manager's notes, or in a dedicated matrix tool. Laying sources side by side makes patterns and gaps easier to see and gives a committee a clear record of how the literature was organized. If your search includes a screening pass you want to document, a written set of inclusion and exclusion criteria (for example, structured around PICOS) applied consistently and logged for each record goes a long way, even without dual screening.
A useful check: if your methods section will cite PRISMA and name a second reviewer, you are doing a systematic review. If your literature review is one chapter written by one person, you are probably not, and in our view paying $339 for dual-screening infrastructure you may never use is likely more than the project needs.
Free and Low-Cost Covidence Alternatives
No single free tool replaces the whole Covidence pipeline, so it is most useful to look at alternatives by project type.
For genuine team-based systematic reviews on a budget
If you need dual screening but cannot access Covidence, dedicated screening tools exist at no or low cost:
- Rayyan offers a free plan. As of September 2026, its pricing page lists the free tier as including 3 active reviews and 2 free invited reviewers, with duplicate detection and AI relevance predictions; paid tiers add more.
- ASReview is free, open-source software for AI-aided screening. It uses active learning, prioritizing records based on your earlier screening decisions, and can be run locally on your own computer.
- Covidence itself also offers some AI-assisted screening features; check its current documentation for details.
Feature sets, integrations, and Cochrane alignment differ across these tools, so check each against your protocol's requirements. For an unfunded team review, they are credible starting points. For a walkthrough of running a screening workflow without a paid platform, see this guide to a free systematic review screening workflow. If AI-assisted retrieval and screening is the part you actually need, this look at whether Elicit is worth its subscription and which free alternatives come close covers that side of the workflow.
For solo structured literature reviews
For a solo, non-systematic review, the needs are organization and synthesis rather than blinded screening. Common options include:
- A spreadsheet-based matrix. Any spreadsheet application can hold a synthesis matrix. It is flexible and familiar, though it takes some setup to keep columns consistent.
- A reference manager with notes and tags. Tools such as Zotero, EndNote, and Mendeley (all of which Covidence integrates with) store citations and let you tag and annotate sources. They handle citation management well; synthesis across studies usually still needs a matrix alongside.
- Browser-based matrix and screening tools. Several free web tools provide a ready-made matrix structure or a simple single-reviewer screening log. Check where each stores your data and export regularly.
The trade-off is worth stating plainly. These routes cost little or nothing, but none of them provides blinded dual-reviewer screening, a built-in risk of bias module, or automatic PRISMA flow diagrams. If your protocol requires those, a solo matrix workflow does not meet it.
For the reporting and write-up stage
Whatever workflow you choose, the review eventually has to become a manuscript or chapter. Covidence's workflow ends at data extraction, so the writing stage is on you either way. A pre-submission checklist covering structure, formatting, reporting guideline items (such as the PRISMA checklist, if it applies), and the target journal's or graduate school's requirements helps catch problems before submission.
Covidence vs Free Alternatives: Side-by-Side
| Capability | Covidence (paid plans) | Rayyan (free plan) | ASReview | Spreadsheet or matrix workflow |
|---|---|---|---|---|
| Price (as of September 2026) | $339/year (1 review); $907/year (3 reviews); free for Cochrane authors | $0 | $0, open source | $0 with free spreadsheet software |
| Scope limits | Priced per review; free trial capped at 500 records | 3 active reviews, 2 free invited reviewers | See vendor documentation | None beyond your software |
| Citation import and deduplication | Yes: imports RIS, EndNote XML, and PubMed formats (CSV is export-side) | Duplicate detection listed on free tier | See vendor documentation | Manual |
| Multi-reviewer screening | Yes, blinded, with conflict resolution | Invited reviewers supported; see vendor documentation for blinding | See vendor documentation | No |
| AI-assisted screening | Some features; check documentation | AI relevance predictions listed on free tier | Core purpose (active learning) | No |
| Risk of bias assessment | Built-in module | See vendor documentation | Not the focus | Manual |
| PRISMA flow diagram export | Yes | See vendor documentation | See vendor documentation | Manual |
| Data extraction and synthesis | Built-in extraction templates | See vendor documentation | Not the focus | Core purpose of a matrix |
| Typical fit | Health sciences teams, Cochrane authors, institution-backed reviews | Small teams needing a no-cost screening start | Researchers screening large record sets who can run software locally | Solo structured and narrative reviews |
Cells marked "See vendor documentation" are features we could not confirm from public pages as of September 2026, so check the current documentation before relying on them.
In our reading, the pattern is clear. Covidence is built for the full systematic review pipeline: deduplication, blinded screening, risk of bias, and PRISMA reporting. Free screening tools cover parts of that pipeline at no cost, with limits you should check against your protocol. Spreadsheet and matrix workflows cover the organization and synthesis work that, in our experience, dominates most non-systematic graduate projects, but they do not do team screening.
When Covidence Is Genuinely Worth the Money
Covidence is a sensible choice in several common situations:
- You are running a true team review. Two or more reviewers, blinded screening, conflict resolution: this is what the platform is built for, and unlimited collaborators on every paid plan makes per-review pricing reasonable for a team, in our view.
- You are publishing in health sciences. Many journals and committees in medicine, nursing, and public health expect Cochrane-style rigor, and Covidence's workflow is built around it.
- You are a Cochrane author. Registered Cochrane reviews get access at no charge.
- Your institution already subscribes. Covidence reports more than 450 universities and institutions with unlimited access; check with your library before paying personally.
- Your search returned thousands of records. Manual screening at that scale invites errors that deduplication and structured screening help prevent.
If none of those apply, it is worth weighing the $339 cost against what your project actually requires.
How to Decide in Three Steps
Step 1: Classify the project. Write one sentence: "My review requires a pre-registered protocol and two independent screeners: yes or no." If no, you are doing a structured literature review, and a matrix-based workflow is likely to fit.
Step 2: Check institutional access. If yes to step 1, ask your library about a Covidence license before spending anything. Institutional access, the Cochrane pathway, and arrangements for teams in low or lower-middle income countries cover many researchers who assume they have to pay.
Step 3: Match the tool to the project. Team systematic review with a license: Covidence. Team systematic review with no license and no budget: Rayyan's free plan or ASReview, checked against your protocol. Solo structured review: a synthesis matrix (spreadsheet or dedicated tool), plus a documented screening log if you screen records. Either path: a pre-submission checklist before you submit.
The Bottom Line on Covidence Alternatives
Covidence is one of the most widely used systematic review collaboration platforms and the Cochrane-recommended screening and extraction tool for standard intervention reviews. In our view it is a well-built product from a not-for-profit developer, and for team-based systematic reviews in the health sciences, especially with institutional access or Cochrane registration, it is a sensible default.
The search for Covidence alternatives is often a sign of a mismatch between the tool and the project. In summary:
- Choose Covidence if you are running a team systematic review with blinded dual screening, especially in the health sciences, or if your institution or Cochrane registration gives you access.
- Consider Rayyan's free plan or ASReview if you need team or AI-assisted screening without a budget, after checking their current features against your protocol.
- Consider a spreadsheet or matrix-based workflow if you are writing a solo structured, narrative, or scoping-style literature review that does not require dual screening or PRISMA reporting.
Free tools from the publisher of this article
Subthesis, which publishes this article, offers free browser-based tools that may help with some of the tasks above:
- Literature Review Matrix: a synthesis matrix for organizing each source's design, sample, outcomes, key findings, limitations, and notes in the browser. No account required.
- Systematic Review Screener: helps a single reviewer apply inclusion and exclusion criteria consistently, with guidance on PICOS criteria and screening practices. It supports single-reviewer workflows only and does not provide blinded dual screening.
- Publication Readiness Checklist: pre-submission checks covering structure, formatting, and submission requirements.
These tools store data in your browser, so export your work regularly. A related resource from the same publisher, The Review Protocol, walks through review methodology decisions step by step.
Covidence is a trademark of Veritas Health Innovation Ltd. Other product names are trademarks of their respective owners and are used only to identify those products.